Babyscripts Raises $5.7 Million to Build the Market's Most Robust, Clinically-Validated Virtual Care Women's Health Platform Washington, DC, June 29, 2017 (GLOBE NEWSWIRE) -- Babyscripts, the leading virtual care women's health platform, announced today that it has raised $5.7 million in new funding. Ysios Capital is the...

Agile Therapeutics to Present Additional Phase 3 Data at the 2017 Annual Clinical and Scientific Meeting of the American Congress of Obstetricians and Gynecologists PRINCETON, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company today announced that data from its Phase 3 SECURE study will be presented at...

Agile Therapeutics Reports Second Quarter 2016 Financial Results PRINCETON, N.J., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...

Jhpiego Recognized for Improving Maternal, Newborn Health BALTIMORE, Md., July 8, 2015 (GLOBE NEWSWIRE) -- Findings from Jhpiego's 20 years of experience leading maternal and newborn health programs have been published in the prestigious International...

Fertility Drugs Increase Thyroid Cancer Risk GAINESVILLE, FL--(Marketwire - October 9, 2009) - Women who take the most common fertility drugs, progesterone and clomiphene, are at a greater risk to develop thyroid cancer than those who don't,...